# EDGAR Filing Document

**Accession Number:** 0001811935
**File Stem:** 0001628279-25-000651
**Filing Date:** 2025-9
**Character Count:** 60756
**Document Hash:** a0cf2ff4781d2521f2832e0d525b5371
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628279-25-000651.hdr.sgml**: 20250925

**ACCESSION NUMBER**: 0001628279-25-000651

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250925

**DATE AS OF CHANGE**: 20250925

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pattern Group Inc.
- **CENTRAL INDEX KEY:** 0001811935
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 832556861
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95241
- **FILM NUMBER:** 251345219

**BUSINESS ADDRESS:**
- **STREET 1:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** 866-765-1355

**MAIL ADDRESS:**
- **STREET 1:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Covalent Group, Inc.
- **DATE OF NAME CHANGE:** 20200513
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wright David K.
- **CENTRAL INDEX KEY:** 0002086238

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043

## Ex-1

**Exhibit 1**

**JOINT FILING AGREEMENT** 

Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules and regulations thereunder, the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Pattern Group Inc., a Delaware corporation, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto. Each of them is responsible for the timely filing of such filings and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

This Agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.

Date: September 25, 2025

---

| | | |
|:---|:---|:---|
| /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact |
|  | David Wright | David Wright |
| /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact |
|  | Melanie Alder | Melanie Alder |
| Wright Irrevocable Trust dated December 5, 2019 | Wright Irrevocable Trust dated December 5, 2019 | Wright Irrevocable Trust dated December 5, 2019 |
| By: | /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact |
|  | Name: | David Wright |
|  | Title: | Trustee |
| By: | /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact |
|  | Name: | Melanie Alder |
|  | Title: | Trustee |
| Alder Irrevocable Trust dated December 5, 2019 | Alder Irrevocable Trust dated December 5, 2019 | Alder Irrevocable Trust dated December 5, 2019 |
| By: | /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact |
|  | Name: | Melanie Alder |
|  | Title: | Trustee |
| By: | /s/ Ben Craven, Attorney-in-Fact | /s/ Ben Craven, Attorney-in-Fact |
|  | Name: | David Wright |
|  | Title: | Trustee |

---

## Ex-2

**Exhibit 2**

**CO-FOUNDER VOTING AGREEMENT**

This CO-FOUNDER VOTING AGREEMENT (this "***Agreement***") is made and entered into as of September 22, 2025 by and among David Wright and Melanie Alder (each, an "***Individual Founder***" and, collectively, the "***Individual Founders***") and, with respect to each Individual Founder, any trust or other entity that may now or in the future hold shares of Common Stock (as defined below) over which such Individual Founder exercises voting control and that executes and delivers a Joinder Agreement hereto in the form of <u>Exhibit A</u> (each such trust and entity, a "***Founder Affiliate***" and, each Individual Founder and Founder Affiliate, a "***Founder***"). The Individual Founders and Founder Affiliates are referred to collectively herein as the "***Founders***". Capitalized terms not otherwise defined herein shall have the meaning given to them in the Amended and Restated Certificate of Incorporation of Pattern Group Inc., a Delaware corporation (the "***Company***"), to be duly adopted in accordance with the General Corporation Law of the State of Delaware and filed with the Secretary of State of the State of Delaware in connection with the IPO (as defined below), as it may be amended, restated or otherwise modified from time to time (the "***Certificate of Incorporation***").

**RECITALS**

**WHEREAS**, on August 22, 2025 the Company publicly filed with the U.S. Securities and Exchange Commission (the "***SEC***") under the Securities Act of 1933, as amended, a registration statement on Form S-1 relating to the initial public offering (the "***IPO***") of shares of Series A common stock, par value $0.001 per share ("***Series A Common Stock***"), of the Company;

**WHEREAS**, immediately following the effective time of the IPO, each Founder will own or beneficially own shares of Series A Common Stock and/or shares of Series B Common Stock, par value $0.001 per share ("***Series B Common Stock***" and, together with the Series A Common Stock, the "***Common Stock***"), of the Company; and

**WHEREAS**, each of the Founders desires to provide for the election or re-election of the Individual Founders to the Board of Directors of the Company (the "***Board***") after the Company has completed the IPO and to vote together on other matters as stockholders of the Company as set forth in this Agreement.

**AGREEMENT**

NOW, THEREFORE, in consideration of the above recitals and the mutual covenants made herein, the parties hereby agree as follows:

1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Voting Provisions</u>.

1.1 <u>Shares</u>. Each Founder expressly agrees that the terms and restrictions of this Agreement shall apply to all shares of Common Stock (or shares of capital stock of any successor in interest of the Company, whether by sale, merger, consolidation or other similar transaction, or by purchase, assignment or operation of law) (i) which such Founder owns or holds or hereafter acquires or holds by any means, including, without limitation, by purchase, assignment, conversion or exercise of any stock option, warrant or other right, the settlement of any restricted stock unit or as a result of any stock dividend, stock split, reorganization, reclassification, whether voluntary or

------

involuntary, or other similar transaction, and (ii) with respect to which such Founder exercises voting control, or hereafter acquires voting control by any means (including, in the case of each of (i) and (ii), as a result of a transfer, assignment, sale or other disposition of any Shares to an Affiliate pursuant to the applicable provisions of the Certificate of Incorporation) (the shares described in (i) and (ii), collectively with respect to each Founder, "***Shares***", *provided*, *however*, that any such shares of Common Stock or other capital stock shall only constitute "Shares" of a Founder for purposes of this Agreement while so held or controlled (with respect to voting) by such Founder), and *provided further*, that shares of Series A Common Stock held by Founder Affiliates set forth on <u>Schedule I</u> to this Agreement ("***Excluded Founder Affiliates***"), as such schedule may be amended, modified or supplemented from time to time in writing signed by each of the Individual Founders, shall not constitute Shares for purpose of this Agreement or otherwise be subject to the agreements contained herein and the Voting Proxy (as defined below) granted hereby.

1.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Ownership</u>. As of the date hereof, each Founder represents and warrants (a) that (i) such Founder owns the Shares as set forth in <u>Schedule II</u> hereto and (ii) excluding the Shares referenced in the preceding clause (i), such Founder beneficially owns or has voting control over the Shares as set forth in <u>Schedule II</u>; and (b) there are no other Shares owned, beneficially owned or over which such Founder has voting control other than those shares of Series A Common Stock held by Excluded Founder Affiliates listed on <u>Schedule I</u>.

1.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Board Composition</u>. Subject to <u>Section 2</u>, during the term of this Agreement, from time to time and at all times, each Founder, in its capacity as a stockholder or beneficial owner of Shares, agrees, following the closing of the IPO, to vote all Shares FOR, or cause all Shares to be voted FOR, the election or re-election of each of the Individual Founders that have been duly nominated for election or re-election as members of the Board at each annual or special meeting of stockholders at which members of the Board are to be elected, and to take all actions by written consent in lieu of any such meeting to approve the election or re-election of each of the Individual Founders that have been duly nominated for election or re-election as members of the Board.

For the avoidance of doubt, nothing in this Agreement requires any Individual Founder to serve as a member of the Board, and any Individual Founder may resign from the Board at any time.

1.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Removal of Board Members</u>. Subject to <u>Section 2</u>, during the term of this Agreement, from time to time and at all times, each Founder, in its capacity as a stockholder or beneficial owner of Shares, agrees, following the closing of the IPO, to vote, or cause to be voted, at any annual meeting or special meeting of stockholders at which any Individual Founder is to be removed from the Board, all Shares AGAINST the removal of such Individual Founder from the Board, and to take all actions by written consent in lieu of any such meeting AGAINST the removal of each such Individual Founder from the Board (and not to take action by written consent to approve any such removal).

1.5&nbsp;&nbsp;&nbsp;&nbsp;<u>No Liability for Election of Individual Founder Directors</u>. No Founder shall have any liability as a result of voting in favor of the election of an Individual Founder to the Board for any act or omission by such Individual Founder in his or her capacity as a member of the Board, nor shall any Founder have any liability as a result of voting for any Individual Founder in accordance with the provisions of this Agreement.

------

1.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Other Voting Obligations</u>. At any annual or special meeting of stockholders of the Company or written consent of stockholders, each Founder agrees to vote such Shares at the written direction of the applicable Individual Founder Proxy Holder (as defined below) for such meeting with respect to any other matters properly brought before such meeting for which the Shares are entitled to vote.

1.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Actions</u>. Each Founder agrees to take all necessary and appropriate action in order to ensure that all of its Shares are voted in accordance with <u>Sections 1.3</u>, <u>1.4</u> and <u>1.7</u>, as applicable, including causing its Shares to be present in person or by proxy for purposes of constituting a quorum at the applicable annual or special meeting of stockholders of the Company. Each Founder further agrees to execute and deliver any written consents, ballots or other documentation representing an action by stockholders of the Company required to perform the obligations of this Agreement.

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Voting Proxy</u>.

2.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Grant of Voting Proxy</u>. Each Individual Founder and his or her Founder Affiliates (the "***Granting Founder***") hereby irrevocably grants to, and appoints the other Individual Founder as such Granting Founder's proxy and attorney-in-fact (with full power of substitution), for and in the name, place and stead of such Granting Founder, to vote or cause to be voted (including by written consent, if applicable) all Shares of such Individual Founder and his or her Founder Affiliates in the manner provided in <u>Sections 1.3</u>, <u>1.4</u> and <u>1.7</u> hereof (the "***Voting Proxy***"), as follows: (a) when neither Individual Founder has suffered an Incapacity, such Voting Proxy shall be given (i) to David Wright, for each annual period beginning on January 1 and ending on December 31 in an odd year, and (ii) to Melanie Alder for each annual period beginning on January 1 and ending on December 31 in an even year; or (b) when either Individual Founder has suffered an Incapacity, such Voting Proxy shall be given to the other Individual Founder (the applicable Individual Founder holder of such Voting Proxy given in clauses (a) and (b) being referred to at any such time herein as the "***Individual Founder Proxy Holder***"). Such Voting Proxy shall be irrevocable until this Agreement terminates pursuant to its terms or this <u>Section 2.1</u> is amended to remove such grant of proxy in accordance with <u>Section 7.6</u> hereof.

2.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Exercise of Proxy</u>. At any annual or special meeting of stockholders of the Company or any request for written consent of stockholders, the Individual Founder Proxy Holder as of the record date of any such meeting or written consent solicitation shall vote all Shares in accordance with the terms of <u>Sections 1.3</u> and <u>1.4</u> of this Agreement, and shall vote all Shares on any other matter pursuant to <u>Section 1.</u>7 as is determined by such Individual Founder Proxy Holder in his or her sole discretion, on all matters submitted to a vote of stockholders of the Company, whether submitted to any individual class of stock voting separately or multiple classes of stock voting together. Each Granting Founder hereby affirms that the irrevocable proxy granted pursuant to <u>Section 2.1</u> is given in connection with the execution of this Agreement, including to secure the performance of the duties of such Granting Founder under <u>Sections 1.3</u>, <u>1.4</u> and <u>1.7</u> and this <u>Section 2</u>.

2.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Excluded Founder Affiliates</u>. Notwithstanding anything in this Agreement to the contrary, no Excluded Founder Affiliate shall have any obligation to vote shares of Series A Common Stock, and is not granting any proxy, pursuant to this Agreement, and each such Excluded Founder

------

Affiliate shall be entitled to vote any shares of capital stock of the Company in its sole and absolute discretion, notwithstanding the fact that any Individual Founder exercises voting or dispositive control over the shares of Series A Common Stock or any other securities held by such Excluded Founder Affiliate.

3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfers</u>. Nothing in this Agreement shall prevent any Founder from transferring its Shares (including through an assignment, sale or other disposition). Upon such transfer, such transferred Shares shall cease to be subject to the Voting Proxy unless transferred to an Individual Founder or Founder Affiliate (other than an Excluded Founder Affiliate).

4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Assurances</u>. At any time or from time to time after the date hereof, the Founders agree to cooperate with each other, and at the request of any Founder, to execute and deliver any further instruments or documents and to take all such further action as the requesting Founder may reasonably request in order to evidence or effectuate the consummation of the obligations contemplated hereby and to otherwise carry out the intent of the Founders hereunder.

5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Remedies</u>.

5.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Enforcement</u>. Each party acknowledges and agrees that each party hereto will be irreparably damaged in the event any of the provisions of this Agreement are not performed by the parties in accordance with their specific terms or are otherwise breached. Accordingly, it is agreed that each of the aggrieved parties shall be entitled to an injunction to prevent breaches of this Agreement, and to specific enforcement of this Agreement and its terms and provisions in any action instituted in any court of the United States or any state having subject matter jurisdiction.

5.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Remedies Cumulative</u>. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Term and Termination</u>. This Agreement shall be conditioned upon and effective as of the closing of the IPO and shall continue in effect until, and shall terminate with respect to all Founders, upon the occurrence of the automatic conversion of all Shares of Series B Common Stock pursuant to a Founders Triggering Event (as defined in the Certificate of Incorporation).

If the closing of the IPO has not occurred by December 31, 2025, this Agreement shall automatically terminate and be of no further force or effect.

7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Miscellaneous.</u>

7.1&nbsp;&nbsp;&nbsp;&nbsp;<u>No Assignment</u>. The terms and conditions of this Agreement, including all obligations and rights therein, may not be assigned.

7.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of law.

7.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts; Facsimile</u>. This Agreement may be executed and delivered by facsimile signature, including electronic signatures, and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

------

7.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Titles and Subtitles</u>. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

7.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (a) personal delivery to the party to be notified, (b) when sent, if sent by facsimile during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient's next business day, (c) when sent, if sent by electronic mail during the recipient's normal business hours, and if not sent during normal business hours, then on the recipient's next business day, (d) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (e) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery with written verification of receipt. All communications shall be sent to the respective parties at their address or email address as set forth below or at such other address as the Individual Founder shall, from time to time, designate to the other by at least five (5) days' advance written notice:

If to David Wright or his Founder Affiliates, to:

David Wright

[ ]

If to Melanie Alder or her Founder Affiliates, to:

Melanie Alder

[ ]

And in each case, with a copy (which shall not constitute notice) to:

Pattern Group Inc.

Attn: General Counsel

[ ]

7.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Consent Required to Terminate, Amend or Waive</u>. This Agreement may be amended or terminated and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument executed by each of the Individual Founders. Any amendment, termination or waiver effected in accordance with this <u>Section 7.6</u> shall be binding on each party.

7.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Delays or Omissions</u>. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting

------

party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

7.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

7.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>. This Agreement shall constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled.

7.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Legend on Share Certificates</u>. Each certificate representing any Shares issued after the date hereof and/or uncertificated book entry ownership reflected on the books and records of the Company or its transfer agent shall be endorsed by the Company with a legend reading substantially as follows:

"THE SHARES EVIDENCED HEREBY ARE SUBJECT TO A VOTING AGREEMENT, AS MAY BE AMENDED FROM TIME TO TIME (THE "VOTING AGREEMENT") (A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST FROM THE INDIVIDUAL FOUNDERS), AND BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING SUCH INTEREST SHALL BE DEEMED TO AGREE TO, AND SHALL BECOME BOUND BY, ALL THE PROVISIONS OF THAT VOTING AGREEMENT UNTIL THE TERMINATION THEREOF AS SET FORTH THEREIN."

The Founders agree to cause the Company to cause any certificates and/or book-entry notation evidencing the Shares issued after the date hereof to bear the legend required by this <u>Section 7.10</u>. The parties to this Agreement do hereby agree that the failure to cause the certificates or book-entry notation evidencing the Shares to bear the legend required by this <u>Section 7.10</u> herein and/or the failure of the Individual Founders to supply, free of charge, a copy of this Agreement as provided hereunder shall not affect the validity or enforcement of this Agreement.

7.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock Splits, Stock Dividends, etc</u>. In the event of any issuance of Shares of the Company's voting securities hereafter to any of the Founders (including, without limitation, in connection with any stock split, stock dividend, recapitalization, reorganization, or the like), such Shares shall become subject to this Agreement and shall be endorsed with the legend set forth in <u>Section 7.10</u>.

7.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Manner of Voting; Grant of Proxy</u>. The voting of Shares pursuant to this Agreement may be effected in person, by proxy, by written consent or in any other manner permitted by applicable law.

7.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Additional Parties</u>. Unless prohibited by applicable law, in the event that after the date of this Agreement, an Individual Founder establishes a Founder Affiliate, then, such Individual

------

Founder shall cause such Founder Affiliate, as a condition to such establishment, to become a party to this Agreement by executing a joinder agreement in the form attached hereto as <u>Exhibit</u> <u>A</u> ("***Joinder Agreement***"), agreeing to be bound by and subject to the terms of this Agreement as a Founder Affiliate, and thereafter such Founder Affiliate shall be deemed a Founder Affiliate for all purposes under this Agreement. No action or consent by the Founders shall be required for such joinder to this Agreement by such additional Founder Affiliate, so long as such additional Founder Affiliate has agreed in writing to be bound by all of the obligations as a "Founder Affiliate" hereunder.

7.14&nbsp;&nbsp;&nbsp;&nbsp;<u>Dispute Resolution</u>. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any Federal court of the United States of America sitting in the State of Delaware) for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any Federal court of the United States of America sitting in the State of Delaware), and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named court(s), that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

7.15&nbsp;&nbsp;&nbsp;&nbsp;<u>Spousal Consent</u>. Each Individual Founder is married to the other Individual Founder on the date of this Agreement, and acknowledges, in each Individual Founder's capacity as a spouse of the other Individual Founder, that each has read this Agreement, knows the contents of this Agreement, and is aware that this Agreement contains provisions regarding the voting and transfer of shares of capital stock of the Company that such spouse may own, including any interest such spouse might have therein. Each Individual Founder, in his or her capacity as a spouse of the other Individual Founder, hereby agrees that such spouse's interest, if any, in any shares of capital stock of the Company subject to this Agreement shall be irrevocably bound by this Agreement and further understands and agrees that any community property interest he or she may have in such shares of capital stock of the Company shall be similarly bound by this Agreement. Each such Individual Founder, in his or her capacity as a spouse of the other Individual Founder, is aware that the legal, financial and related matters contained in this Agreement are complex and that he or she is free to seek independent professional guidance or counsel with respect to this Agreement, and has either sought such guidance or counsel or determined after reviewing this Agreement carefully that he or she will hereby waive such right.

Notwithstanding the execution and delivery hereof, the consent in this <u>Section 7.15</u> shall not be deemed to confer or convey to the respective spouse of the other Individual Founder any rights in such Individual Founder's Shares that do not otherwise exist by operation of law or the agreement of the parties.

If any Individual Founder should marry or remarry subsequent to the date of this Agreement and, subject to the earlier termination of this Agreement pursuant to <u>Sections 6</u> or <u>7.6</u>, such Individual

------

Founder shall within thirty (30) days thereafter obtain his/her new spouse's acknowledgement of and consent to the existence and binding effect of all restrictions contained in this Agreement by causing such spouse to execute and deliver a similar consent of such spouse acknowledging the restrictions and obligations contained in this Agreement and agreeing and consenting to the same.

**[SIGNATURE PAGES FOLLOW]**

------

**IN WITNESS WHEREOF**, the parties have caused this Agreement to be executed as of the date first written above.

---

| |
|:---|
| /s/ David Wright |
| DAVID WRIGHT |
| /s/ Melanie Alder |
| MELANIE ALDER |

---

------

**<u>Schedule I</u>**

**<u>Excluded Founder Affiliates</u>**

---

| | |
|:---|:---|
| **<u>Record Holder</u>** | **<u>Series A Common Stock</u>** |
| The Wright Irrevocable Trust dated December 5, 2019 | 45,297,280 |
| The Alder Irrevocable Trust dated December 5, 2019 | 29,418,585 |

---

------

**<u>Schedule II</u>**

<u>Share Ownership</u>

---

| | | |
|:---|:---|:---|
| **<u>Record Holder</u>** | **<u>Series A Common Stock</u>** | **<u>Series B Common Stock</u>** |
| David Wright | 105,281 | 13,025,878 |
| Melanie Alder | 35,093 | 8,676,632 |

---

------

**<u>Exhibit A</u>**

Form of Joinder Agreement

<u>Joinder Agreement to Voting Agreement</u>

The undersigned hereby acknowledges that it has reviewed and understands the Co-Founder Voting Agreement (as amended, supplemented, or otherwise modified from time to time in accordance with the terms thereof, the "***Voting Agreement***") dated as of September 22, 2025, by and among David Wright and Melanie Alder (each, an "***Individual Founder***" and, collectively, the "***Individual Founders***") and, with respect to each Individual Founder, the Founder Affiliates, and agrees to be bound as a Founder Affiliate by the terms and conditions thereof. Capitalized terms used but not defined in this Joinder Agreement shall have the respective meanings ascribed to such terms in the Voting Agreement.

By execution of this Joinder Agreement, the undersigned hereby (a) agrees that the shares of Common Stock over which <u>[</u>insert name of Individual Founder<u>]</u> exercises voting control shall be bound by and subject to the terms of the Voting Agreement and (b) adopts the Voting Agreement with the same force and effect as if the undersigned were originally a party thereto.

This Joinder Agreement shall be governed by the governing law set forth in the Voting Agreement.

---

| |
|:---|
| **FOUNDER AFFILIATE:** |
| By: |
| <u>Name and Title of Signatory</u> |
| Address: |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Pattern Group Inc.**

*(Name of Issuer)*

**Series A Common Stock**

*(Title of Class of Securities)*

**70339W104**

*(CUSIP Number)*

**David K. Wright**<br>1441 West Innovation Way, Suite 500<br>Lehi UT 84043<br>(866) 765-1355

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**09/18/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **70339W104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**David K. Wright** | Name of reporting person<br>**David K. Wright** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**96558749.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**96558749.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**96558749.00** | Aggregate amount beneficially owned by each reporting person<br>**96558749.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**62.6%** | Percent of class represented by amount in Row (11)<br>**62.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** 8) Shared voting power:
Includes shares subject to the Voting Agreement (as defined below). Such Voting Agreement contains provisions relating to the voting of the Common Stock (as defined below) held by the parties thereto. Accordingly, Mr. Wright may be deemed to share beneficial ownership of such shares held by such parties until the termination of the Voting Agreement.

13) Percent of class represented by amount in Row (11):
Calculated pursuant to Rule 13d-3 of the Exchange Act. See Item 5.

Consists of (i) 13,025,878 shares of Series B Common Stock (as defined below) held by Mr. Wright, (ii) 105,281 shares of Series A Common Stock (as defined below) issued upon the net settlement of outstanding RSUs held by Mr. Wright that vested based on the satisfaction of service-based and liquidity-based vesting conditions, (iii) 45,297,280 shares of Series A Common Stock held by the Wright Trust (as defined below) of which Mr. Wright and Ms. Alder serve as co-trustees, (iv) 8,676,632 shares of Series B Common Stock held by Ms. Alder, who is the spouse of Mr. Wright, (v) 35,093 shares of Series A Common Stock issued upon the net settlement of outstanding RSUs held by Ms. Alder that vested based on the satisfaction of service-based and liquidity-based vesting conditions, and (vi) 29,418,585 shares of Series A Common Stock held by the Alder Trust (as defined below) of which Mr. Wright and Ms. Alder serve as co-trustees.

Each share of Series B Common stock is convertible at any time at the option of the holder into one share of Series A Common Stock. The holders of Series B Common stock are entitled to twenty votes per share, and holders of Series A Common Stock are entitled to one vote per share.

| **CUSIP No.** | **70339W104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Melanie Alder** | Name of reporting person<br>**Melanie Alder** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**96558749.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**96558749.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**96558749.00** | Aggregate amount beneficially owned by each reporting person<br>**96558749.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**62.6%** | Percent of class represented by amount in Row (11)<br>**62.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** 8) Shared voting power:
Includes shares subject to the Voting Agreement. Such Voting Agreement contains provisions relating to the voting of the Common Stock held by the parties thereto. Accordingly, Ms. Alder may be deemed to share beneficial ownership of such shares held by such parties until the termination of the Voting Agreement.

13) Percent of class represented by amount in Row (11):
Calculated pursuant to Rule 13d-3 of the Exchange Act. See Item 5.

Consists of (i) 8,676,632 shares of Series B Common Stock held by Ms. Alder, (ii) 35,093 shares of Series A Common Stock issued upon the net settlement of outstanding RSUs held by Ms. Alder that vested based on the satisfaction of service-based and liquidity-based vesting conditions, (iii) 29,418,585 shares of Series A Common Stock held by the Alder Trust of which Ms. Alder and Mr. Wright serve as co-trustees, (iv) 13,025,878 shares of Series B Common Stock held by Mr. Wright, who is the spouse of Ms. Alder, (v) 105,281 shares of Series A Common Stock issued upon the net settlement of outstanding RSUs held by Mr. Wright that that vested based on the satisfaction of service-based and liquidity-based vesting conditions, and (vi) 45,297,280 shares of Series A Common Stock held by the Wright Trust of which Mr. Wright and Ms. Alder serve as co-trustees.

Each share of Series B Common stock is convertible at any time at the option of the holder into one share of Series A Common Stock. The holders of Series B Common stock are entitled to twenty votes per share, and holders of Series A Common Stock are entitled to one vote per share.

| **CUSIP No.** | **70339W104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Wright Irrevocable Trust dated December 5, 2019** | Name of reporting person<br>**Wright Irrevocable Trust dated December 5, 2019** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**UTAH** | Citizenship or place of organization<br>**UTAH** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**45297280.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**45297280.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**45297280.00** | Aggregate amount beneficially owned by each reporting person<br>**45297280.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**29.4%** | Percent of class represented by amount in Row (11)<br>**29.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** 13) Percent of class represented by amount in Row (11):
Calculated pursuant to Rule 13d-3 of the Exchange Act. See Item 5.

Consists of 45,297,280 shares of Series A Common Stock held by the Wright Trust. Mr. Wright and Ms. Alder serve as co-trustees of, and may be deemed to indirectly beneficially own securities owned by, the Wright Trust.

| **CUSIP No.** | **70339W104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Alder Irrevocable Trust dated December 5, 2019** | Name of reporting person<br>**Alder Irrevocable Trust dated December 5, 2019** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**UTAH** | Citizenship or place of organization<br>**UTAH** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**29418585.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**29418585.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**29418585.00** | Aggregate amount beneficially owned by each reporting person<br>**29418585.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.1%** | Percent of class represented by amount in Row (11)<br>**19.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** 13) Percent of class represented by amount in Row (11):
Calculated pursuant to Rule 13d-3 of the Exchange Act. See Item 5.

Consists of 29,418,585 shares of Series A Common Stock held by the Alder Trust of which Ms. Alder and Mr. Wright serve as co-trustees.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Series A Common Stock

**(b) Name of Issuer:**
Pattern Group Inc.

**(c) Address of Issuer's Principal Executive Offices:**
1441 West Innovation Way, Suite 500, Lehi, UT, 84043

This Statement relates to the Series A Common Stock, par value $0.001 per share (the "Series A Common Stock"), of Pattern Group Inc., a Delaware corporation (the "Issuer"). The address of the Issuer's principal executive offices is 1441 West Innovation Way, Suite 500, Lehi, UT 84043.

**Item 4. Purpose of Transaction**

The information set forth in Items 3 and 6 of this Schedule 13D is hereby incorporated by reference into this Item 4.

Mr. Wright and Ms. Alder each intend to review each of their respective investments in the Issuer on a continuing basis. Any actions Mr. Wright and Ms. Alder might each undertake may be made at any time and from time to time without prior notice and will be dependent upon each of their respective review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments. In connection with the vesting, settlement or exercise of equity awards of the Issuer, Mr. Wright and Ms. Alder may each have shares of Common Stock withheld for taxes or sold in open-market transactions in connection with the payment of applicable taxes or otherwise. Any transactions in Common Stock of the Issuer by either Mr. Wright or Ms. Alder pursuant to the Voting Agreement with respect to shares of Common Stock that they each hold may be taken at any time.

Mr. Wright and Ms. Alder, subject to certain provisions of the law, may each respectively acquire additional securities of the Issuer, or retain or sell all or a portion of the securities then held, in the open market or in privately negotiated transactions. In addition, each of Mr. Wright, including in his positions as Chief Executive Officer, member of the Board and Chairperson thereto, and Ms. Alder, including in her positions as Chief Strategy Officer and member of the Board, may engage in discussions with other members of management, the Board, and stockholders of the Issuer and other relevant parties or encourage, cause or seek to cause the Issuer or such persons to consider or explore extraordinary corporate transactions, such as: a merger, reorganization or take-private transaction that could result in the de-listing or de-registration of the Series A Common Stock; security offerings and/or stock repurchases by the Issuer; sales or acquisitions of assets or businesses; changes to the capitalization or dividend policy of the Issuer; or other material changes to the Issuer's business or corporate structure, including changes in management or the composition of the Board.

Other than as described above, each of Mr. Wright and Ms. Alder do not currently have any plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D, although, depending on the factors discussed herein, Mr. Wright and Ms. Alder may change each of their respective purpose or formulate different plans or proposals with respect thereto at any time.

Mr. Wright, including in his positions as Chief Executive Officer, member of the Board and Chairperson thereto, and Ms. Alder, including in her positions as Chief Strategy Officer and member of the Board, each participate in deliberations of the Issuer's senior management in the normal course of the Issuer's business that could involve any of the matters set forth in Items 4(a)-(j) of Schedule 13D from time to time, and, in keeping with each of their respective fiduciary duties as an officer and director, may make proposals or recommendations to the Board that could involve such matters from time to time.

In addition, as members of the Issuer's senior management, each of Mr. Wright and Ms. Alder participates in Issuer compensatory plans, including plans pursuant to which awards of equity securities are made (including to each of Mr. Wright and Ms. Alder), in the ordinary course of business.

As a result of the Voting Agreement, Mr. Wright and Ms. Alder may be deemed a group for purposes of Section 13(d)(3) of the Exchange Act.

**Item 5. Interest in Securities of the Issuer**

**(a)**
(a)-(b) The aggregate number and percentage of shares of Series A Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by reference.

Beneficial ownership of shares of Series A Common Stock, par value $0.001 per share,  includes shares of Series A Common Stock which may be acquired upon the conversion of shares of the Issuer's Series B Common Stock, par value $0.001 per share (the "Series B Common Stock" and, together with the Series A Common Stock, the "Common Stock"). Holders of Series A Common Stock and Series B Common Stock generally vote together as a single class, unless otherwise required by law, the Issuer's amended and restated certificate of incorporation, or the Issuer's amended and restated bylaws. Each share of Series A Common Stock is entitled to one vote. Each share of Series B Common Stock is entitled to twenty votes per share and is convertible at any time at the option of the holder into one share of Series A Common Stock.

As of the date hereof, Mr. Wright and Ms. Alder each beneficially own 96,558,749 shares of Series A Common Stock, representing beneficial ownership of approximately 62.6% of the outstanding Series A Common Stock, and approximately 54.8% of the total outstanding Common Stock, consisting of: (i) 13,025,878 shares of Series B Common Stock held by Mr. Wright, (ii) 105,281 shares of Series A Common Stock issued upon the net settlement of outstanding RSUs held by Mr. Wright that vested based on the satisfaction of service-based and liquidity-based vesting conditions, (iii) 45,297,280 shares of Series A Common Stock held by the Wright Trust of which Mr. Wright and Ms. Alder serve as co-trustees, (iv) an aggregate of 8,676,632 shares of Series B Common Stock held by Ms. Alder, who is married to Mr. Wright, (v) 35,093 shares of Series A Common Stock issued upon the net settlement of outstanding RSUs held by Ms. Alder that vested based on the satisfaction of service-based and liquidity-based vesting conditions, and (vi) 29,418,585 shares of Series A Common Stock held by the Alder Trust of which Mr. Wright and Ms. Alder serve as co-trustees.

As of the date hereof, the Wright Trust beneficially owns 45,297,280 shares of Series A Common Stock, and the Alder Trust beneficially owns 29,418,585 shares of Series A Common Stock.

Calculations of the percentage of the outstanding Series A Common Stock and total outstanding Common Stock beneficially owned by the Reporting Persons are based on (i) 154,317,165 shares of Series A Common Stock reported to be outstanding after the Issuer's initial public offering ("IPO") as disclosed in its final prospectus filed with the SEC on September 19, 2025, and (ii) 21,702,510 shares of Series B Common Stock held in the aggregate by Mr. Wright and Ms. Alder, where each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock.

**(b)**
The information set forth in Item 5(a) of this Schedule 13D is hereby incorporated by reference.

**(c)**
Immediately prior to the completion of the Issuer's IPO, (i) all outstanding shares of Issuer's series A preferred stock automatically converted into an equal number of shares of Issuer's then-existing common stock (the "Series A Preferred Stock Conversion"); (ii) all 13,215,614 outstanding shares of Issuer's series B preferred stock automatically converted into an aggregate of 32,129,232 shares of Issuer's then-existing common stock, based on the IPO price of $14.00 per share, after giving effect to certain anti-dilution adjustments dependent on the IPO price pursuant to the terms of Issuer's amended and restated certificate of incorporation then in effect (the "Series B Preferred Stock Conversion" and, together with the Series A Preferred Stock Conversion, the "Convertible Preferred Stock Conversion"); (iii) Issuer's outstanding then-existing common stock were reclassified into an equivalent number of shares of Series A Common Stock (including shares of Issuer's then-existing common stock issued automatically upon the Convertible Preferred Stock Conversion immediately prior to the completion of the IPO) (the "Common Stock Reclassification"); and (iv) 17,797,821 shares of Issuer's founder voting preferred stock were reclassified into an aggregate of 21,702,510 shares of Series B Common Stock, and 68,994,553 shares of founder non-voting preferred stock were reclassified into an aggregate of 84,131,370 shares of Series A Common Stock (the "Founder Preferred Stock Reclassifications" and, together with the Common Stock Reclassification, the "Reclassifications").

Immediately prior to the completion of the Issuer's IPO, Mr. Wright and Ms. Alder were issued 105,281 and 35,093 shares of Series A Common Stock, respectively, upon net settlement of RSUs that vested based on service and liquidity conditions.

Immediately prior to the completion of the Issuer's IPO, as described further in Item 6 below, Mr. Wright and Ms. Alder entered into a Voting Agreement pursuant to which each may be deemed to have acquired beneficial ownership over the other's shares of Common Stock through the Voting Proxies.

On September 22, 2025, the Issuer completed its IPO of an aggregate of 21,428,572 shares of Series A Common Stock at a price to the public of $14.00 per share, 10,714,286 of which shares were sold by the Issuer and 10,714,286 of which shares were sold by certain selling stockholders.

In connection with the closing of the IPO, (i) the Wright Trust sold 5,694,671 shares of Series A Common Stock, and (ii) the Alder Trust sold 3,719,615 shares of Series A Common Stock, at a price of $13.02 per share, which is equal to the public offering price of $14.00 per share minus the underwriting discount and commission of $0.98 per share. The shares were sold pursuant to an underwriting agreement by and among the Issuer, the representatives of the underwriters and the selling stockholders named therein, dated September 18, 2025. The underwriters to the IPO have the option to purchase up to an additional 3,214,285 shares of Series A common stock from the Wright Trust and Alder Trust, at a price of $13.02 per share, which is equal to the public offering price of $14.00 per share minus the underwriting discount and commission of $0.98 per share, for 30 days from September 18, 2025.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Executive and Director Compensation
Each of Mr. Wright, including in his positions as Chief Executive Officer, member of the Board and Chairperson thereto, and Ms. Alder, including in her positions as Chief Strategy Officer and member of the Board, has in the past and may in the future receive compensation in the form of Common Stock, restricted stock units, stock options or other securities convertible into Common Stock of the Issuer.

Co-Founder Voting Agreement
Immediately prior to the completion of the Issuer's IPO, Mr. Wright and Ms. Alder entered into a co-founder voting agreement (the "Voting Agreement"). The Voting Agreement provides that an aggregate of 21,702,510 shares of Series B Common Stock held by the Co-founders following the completion of the IPO, or approximately 73.8% of the voting power of the Issuer's Common Stock, will be subject to a voting proxy given by each Co-founder and its affiliated entities (other than the Wright Trust and Alder Trust) to the other Co-founder (the "Voting Proxies"), and an agreement by each Co-founder to vote its shares (a) in favor of the election or re-election of each of the Co-founders that have been duly nominated for election or re-election as members of the Board at each annual or special meeting of stockholders at which directors are to be elected, (b) against the removal of each Co-founder at any annual meeting or special meeting of stockholders at which any Co-founder is to be removed from the Board, and (c) at the written direction of the applicable Co-founder proxy holder (as defined below) at any annual or special meeting of stockholders with respect to any other matters properly brought before such meeting for which their shares are entitled to vote. The applicable "co-founder proxy holder" shall be either Mr. Wright or Ms. Alder in alternative annual periods during which any applicable annual or special meeting is held. Nothing in the Voting Agreement requires either Co-founder to serve as a director or stand for re-election.

The Voting Agreement does not include shares of Series A Common Stock held by the Wright Trust or Alder Trust at the time of the IPO, but may include future affiliated entities of the Co-founders which may hold Common Stock in the future. The Co-founders can modify or terminate the Voting Agreement at any time.

The foregoing description of the Voting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Voting Agreement, which is filed as Exhibit 2 hereto and is incorporated by reference herein.

Lock-Up Agreement
The Issuer and its officers, directors, including Mr. Wright and Ms. Alder, selling stockholders and holders of substantially all of the Issuer's common stock and securities convertible into or exchangeable for shares of the Issuer's common stock have agreed with the underwriters to the Issuer's IPO pursuant to a lock-up agreement (the "Lock-Up Agreement") that, subject to certain exceptions, the earlier of (i) the opening of trading on the second business day immediately following the Issuer's public release of earnings for the second quarter following the most recent period for which financial statements are included in the Issuer's IPO final prospectus and (ii) the date that is 180 days after the date of such prospectus, the Issuer and they will not, without the prior written consent of Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, transfer, dispose of or hedge any shares of Common Stock or any securities convertible into or exchangeable for shares of Common Stock. Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, in their sole discretion, may release any of the securities subject to these lock-up agreements at any time.

The foregoing description of the Lockup Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Lockup Agreement, which is filed as Exhibit 3 hereto and is incorporated by reference herein.

Joint Filing Agreement
Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the Reporting Persons have entered into an agreement, attached hereto as Exhibit 1, with respect to the joint filing of this Schedule 13D and any amendment or amendments hereto (the "Joint Filing Agreement").

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** David K. Wright

**Signature:** /s/ Ben Craven, Attorney-in-Fact

**Name/Title:** Ben Craven/Attorney-in-Fact

**Date:** 09/25/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Melanie Alder

**Signature:** /s/ Ben Craven, Attorney-in-Fact

**Name/Title:** Ben Craven/Attorney-in-Fact

**Date:** 09/25/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Wright Irrevocable Trust dated December 5, 2019

**Signature:** /s/ Ben Craven, Attorney-in-Fact

**Name/Title:** Ben Craven/Attorney-in-Fact

**Date:** 09/25/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Alder Irrevocable Trust dated December 5, 2019

**Signature:** /s/ Ben Craven, Attorney-in-Fact

**Name/Title:** Ben Craven/Attorney-in-Fact

**Date:** 09/25/2025